İbrahim Vedat Bayoğu

15PUBLICATIONS
83CO-AUTHORS
Predictive and prognostic markersMedical mycologyMolecular targetsChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 15, 2026
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies.

|Jun 17, 2026
Stage-dependent prognostic impact of age in colorectal cancer: A population-based SEER analysis.

|Apr 21, 2026
Anxiety and screening attitudes in breast cancer patients and their first-degree relatives: A comparative pilot study.

|Jan 28, 2026
Prognostic Value of Systemic Immune-Inflammation Index in Mucosal Malignant Melanoma.

Burak Paçacı, Erkam Kocaaslan, Ahmet Demirel

|Jan 28, 2026
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab.

Erkam Kocaaslan, Ali Kaan Güren, Fırat Akagündüz

|Jan 28, 2026
Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab.

Erkam Kocaaslan, Ali Kaan Güren, Fırat Akagündüz

Pageof 3

Frequent Collaborators

10 joint publications

Nadiye Sever

9 joint publications

Murat Sarı

9 joint publications

Ali Kaan Güren

8 joint publications

Nargiz Majidova